Banque Cantonale Vaudoise’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Hold |
827
| – | – | ﹤0.01% | 623 |
|
|
2025
Q1 | $67K | Buy |
+827
| New | +$67K | ﹤0.01% | 662 |
|
|
2024
Q3 | $124K | Sell |
1,253
-13,446
| -91% | -$1.33M | 0.01% | 531 |
|
|
2024
Q2 | $1.36M | Buy |
14,699
+500
| +4% | +$46.4K | 0.05% | 298 |
|
|
2024
Q1 | $1.35M | Buy |
14,199
+3,179
| +29% | +$302K | 0.05% | 315 |
|
|
2023
Q4 | $984K | Sell |
11,020
-2,617
| -19% | -$234K | 0.04% | 348 |
|
|
2023
Q3 | $995K | Buy |
13,637
+844
| +7% | +$61.6K | 0.05% | 319 |
|
|
2023
Q2 | $1.07M | Buy |
12,793
+1,021
| +9% | +$85K | 0.05% | 328 |
|
|
2023
Q1 | $898K | Buy |
11,772
+301
| +3% | +$23K | 0.04% | 329 |
|
|
2022
Q4 | $953K | Buy |
11,471
+3,526
| +44% | +$293K | 0.05% | 309 |
|
|
2022
Q3 | $631K | Buy |
7,945
+1,485
| +23% | +$118K | 0.04% | 438 |
|
|
2022
Q2 | $480K | Buy |
6,460
+31
| +0.5% | +$2.3K | 0.02% | 502 |
|
|
2022
Q1 | $578K | Sell |
6,429
-679
| -10% | -$61K | 0.02% | 519 |
|
|
2021
Q4 | $796K | Sell |
7,108
-1,427
| -17% | -$160K | 0.03% | 468 |
|
|
2021
Q3 | $1.07M | Sell |
8,535
-37
| -0.4% | -$4.65K | 0.05% | 399 |
|
|
2021
Q2 | $1.16M | Buy |
8,572
+225
| +3% | +$30.5K | 0.05% | 394 |
|
|
2021
Q1 | $1.13M | Buy |
8,347
+2,487
| +42% | +$337K | 0.06% | 339 |
|
|
2020
Q4 | $825K | Buy |
5,860
+3,397
| +138% | +$478K | 0.05% | 350 |
|
|
2020
Q3 | $274K | Buy |
+2,463
| New | +$274K | 0.02% | 602 |
|
|
2020
Q2 | – | Sell |
-1,328
| Closed | -$103K | – | 958 |
|
|
2020
Q1 | $103K | Sell |
1,328
-1,040
| -44% | -$80.7K | 0.01% | 764 |
|
|
2019
Q4 | $225K | Buy |
+2,368
| New | +$225K | 0.02% | 701 |
|